Scientifically
Acclaimed Therapy in HE
Acclaimed Therapy in HE
L-Ornithine L-Aspartate 5.0/10 ml ampoule IV
- Dual-amino acid pharmaconutrient for reversing minimal HE and preventing progression to overt HE.
- Delivers 3.22 × higher likelihood of overt HE-free status within just 7 days.
- Supports better cognition in acute liver failure-related HE while improving PSE index.
- Shortens hospitalization by 2.21 days, lowers toxic ammonium (NH3) plasma levels, and boosts quality of life.
Dosage
IV: Dilute in 250-500 mL NS/ Dextrose; infuse over 4-6 hours.
Indications:
- Hepatic Encephalopathy (HE)
- Liver Cirrhosis
- Acute Liver Failure
